Related Experiment Video
Updated: Nov 25, 2025

Author Spotlight: Efficiently Eliminating Bacteriophages from Infected Salmonella Cultures Using Lipopolysaccharides
Published on: June 28, 2024
Beyond antibacterials - exploring bacteriophages as antivirulence agents
Yang Shen1, Martin J Loessner1
1Institute of Food, Nutrition and Health, ETH Zurich, Schmelzbergstrasse 7, 8092 Zurich, Switzerland.
Abstract:
Life-threatening infections caused by multidrug-resistant bacteria are becoming increasingly difficult to treat. There is growing interest in exploiting bacteriophages (or phages) to combat bacterial infections. Phages often target bacterial surface structures that may also be important for virulence. Upon phage challenge, these molecules may be lost or modified, resulting in phage resistance and possibly phenotypical conversion. Importantly, possible trade-offs may include lower fitness, increased sensitivity to antibiotics and immune defense mechanisms, and virulence attenuation. Although evolution of phage-resistance may be difficult to prevent, the trade-off phenomenon carries potential for antibacterial therapy. Here we present some insights into the molecular principles and significance of this coincidental interplay between phages, bacteria, and immune cells, and discuss the prospect of developing phage-derived products as antivirulence agents.
Insights
Bacteriophages (phages) can combat multidrug-resistant bacteria by targeting virulence factors. Phage resistance may lead to reduced bacterial fitness and virulence, offering potential for novel antibacterial therapies.
Area of Science:
- Microbiology
- Bacteriology
- Immunology
Background:
- Multidrug-resistant bacterial infections pose a significant global health threat.
- Bacteriophages (phages) are viruses that infect bacteria and are being explored as therapeutic agents.
- Phages interact with bacterial surface structures crucial for both infection and virulence.
Purpose of the Study:
- To explore the molecular mechanisms underlying the interplay between phages, bacteria, and host immune responses.
- To investigate the potential of phage-resistance evolution as an antibacterial therapeutic strategy.
- To discuss the development of phage-derived products as antivirulence agents.
Main Methods:
- Review of existing literature on phage-bacteria interactions.
- Analysis of molecular principles governing phage resistance and its consequences.
- Discussion of evolutionary trade-offs in bacterial response to phage challenge.
Main Results:
- Phage challenge can lead to the loss or modification of bacterial surface structures.
- Acquired phage resistance may result in reduced bacterial fitness, increased susceptibility to antibiotics, and attenuated virulence.
- These trade-offs represent a potential avenue for therapeutic intervention.
Conclusions:
- The evolution of phage resistance in bacteria can inadvertently weaken them.
- Exploiting these phage-induced trade-offs offers a promising strategy for developing novel antivirulence therapies.
- Phage-derived products hold potential for combating challenging bacterial infections.
Related Concept Videos
Lytic Cycle of Bacteriophages
DNA Bacteriophages
Lysogenic Cycle of Bacteriophages
Gene Regulation in Microbial Communities: Quorum Sensing
Viral Replication: Lytic Cycle
Viral Replication: Lysogenic Cycle

